← Back to Search

E4E Intervention Group for Type 2 Diabetes (E4E Trial)

Phase 2
Waitlist Available
Led By Michael Green, MD
Research Sponsored by Queen's University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 2 weeks after the e4e workshop; 1 year later after the completion of e4e intervention
Awards & highlights

E4E Trial Summary

Education for Equity (E4E)intervention intends to improve care delivery through a well designed educational program that address not only the issues of diabetes care delivery to Aboriginal patients with diabetes, but also the issues of effective cross-cultural and culturally safe communication between healthcare providers and Aboriginal patients, and the issues related to effective implementation of appropriate chronic disease management programs for Aboriginal patients in a range of practice settings. The purpose of this study is to evaluate the effectiveness of the E4E education program through measuring patient clinical outcomes, patient experience with their doctors, and the changes in physicians' approaches to care perceived by Aboriginal diabetic patients.

Eligible Conditions
  • Type 2 Diabetes
  • Cultural Competency

E4E Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 2 weeks after the e4e workshop; 1 year later after completetion of e4e intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and within 2 weeks after the e4e workshop; 1 year later after completetion of e4e intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Cultural safety, bias and discrimination--change is being assessed
Hemoglobin A1C values--change is being assessed
Secondary outcome measures
BMI (value, date)--change is being assessed
Blood pressure (systolic, diastolic, date)--change is being assessed
Diabetes counseling and education--change is being assessed
+6 more
Other outcome measures
Clinic visits--change is being assessed
Referrals (to whom and date)--change is being assessed

E4E Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: E4E Intervention GroupExperimental Treatment1 Intervention
E4E Intervention Group is a group of family physicians who will participate in the first wave of E4E intervention.
Group II: E4E Late Intervention Control GroupPlacebo Group1 Intervention
E4E Late Intervention Control Group is a group of family physicians who will participate in the second wave of E4E intervention 12 month later after the completion of the first wave of E4E intervention.

Find a Location

Logistics

Travel, including flights, are covered

Your expenses for travel tickets for this trial will be reimbursed.

Who is running the clinical trial?

Queen's UniversityLead Sponsor
366 Previous Clinical Trials
117,677 Total Patients Enrolled
University of CalgaryOTHER
792 Previous Clinical Trials
868,294 Total Patients Enrolled
Laurentian UniversityOTHER
4 Previous Clinical Trials
495 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~76 spots leftby May 2025